Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer
- 14 July 2011
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 311 (2) , 152-159
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Influence of the prodrugs 5‐fluorocytosine and CPT‐11 on ovarian cancer cells using genetically engineered stem cells: tumor‐tropic potential and inhibition of ovarian cancer cell growthCancer Science, 2010
- The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cellsCancer Gene Therapy, 2009
- Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapyJournal of Neuro-Oncology, 2009
- Stem cell‐based cell therapy in neurological diseases: A reviewJournal of Neuroscience Research, 2009
- Human Neural Stem Cells Can Target and Deliver Therapeutic Genes to Breast Cancer Brain MetastasesMolecular Therapy, 2009
- Development of a Tumor-Selective Approach to Treat Metastatic CancerPLOS ONE, 2006
- Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor RegressionClinical Cancer Research, 2006
- A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study1Neuro-Oncology, 2006
- Recent developments in the use of chemotherapy in brain tumoursEuropean Journal of Cancer, 2006
- Brain metastasesCurrent Problems in Surgery, 2004